Ind-Swift Laboratories informs about interest payment

22 Jun 2023 Evaluate
Pursuant to Regulation 57 (4) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Ind-Swift Laboratories has informed about details of interest obligations in respect of the Non-Convertible Debentures of the Company, which are due to be paid during the quarter ending 30th September, 2023-Q2 F/Y 2023-24.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

105.40 -2.03 (-1.89%)
21-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.10
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 875.10
Lupin 2140.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×